• Helping you understand who owns the world, and how you can invest in it.
  • Follow us

Edgewise Therapeutics, Inc.

Edgewise Therapeutics, Inc.

Public
EDGR
United States
SectorHealthcare
CountryUnited States
Market cap3.50B
A clinical-stage biopharmaceutical company developing targeted genetic medicines for severe neuromuscular diseases.

Where to buy Edgewise Therapeutics, Inc. (EDGR)

EDGR trades on these platforms. Substox may earn a commission if you open an account through one of these links, at no cost to you. It never changes what the data on this page says. Substox is not a licensed financial adviser and this is not investment advice.

Similar public companies in Healthcare